Lopatin Uri A
Chief Med. Off., VP Res. Dev. at ASMB
- Sold, on record
- $623k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Sep 6, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ASMBASSEMBLY BIOSCIENCES, INC.Chief Med. Off., VP Res. Dev.
Sales by reason
0
Routine
1
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Sep 6, 2018Plan not stated
Sold 2.5% of their holdings
$623k15,540 shares at $40.09
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | Aug 31, 2023 | FS Development Corp. II | Director | Tendered | 5.7M | 0 | SEC | ||
| Aug 31, 2023 | Aug 31, 2023 | FS Development Corp. II | Director | Returned to the companyStock Option (Right to Buy) | 458,500 | 0 | SEC | ||
| Jun 1, 2023 | Jun 2, 2023 | FS Development Corp. II | Director | AwardedStock Option (Right to Buy) | 37,500 | 37,500 | SEC | ||
| Feb 1, 2022 | Feb 2, 2022 | FS Development Corp. II | President and CEO | AwardedStock Option (Right to Buy) | 421,000 | 421,000 | SEC | ||
| Mar 29, 2019 | Apr 2, 2019 | ASMB | Chief Medical Officer | AwardedStock Option (right to buy) | 27,500 | 27,500 | SEC | ||
| Mar 29, 2019 | Apr 2, 2019 | ASMB | Chief Medical Officer | Awarded | 13,750 | 627,361 | SEC | ||
| Sep 6, 2018 | Sep 7, 2018 | ASMB | Chief Med. Off., VP Res. Dev. | Sold | 15,540 | $40.09 | $623k | 613,611 | SEC |
| Mar 29, 2018 | Mar 30, 2018 | ASMB | Chief Med. Off., VP Res. Dev. | AwardedStock Option (right to buy) | 15,000 | 15,000 | SEC | ||
| Mar 29, 2018 | Mar 30, 2018 | ASMB | Chief Med. Off., VP Res. Dev. | Awarded | 7,500 | 629,151 | SEC | ||
| Mar 29, 2017 | Mar 31, 2017 | ASMB | Chief Med. Off., VP Res. Dev. | AwardedStock Option (right to buy) | 12,500 | 12,500 | SEC | ||
| Jul 10, 2014 | Jul 14, 2014 | ASMB | Chief Med. Off., VP Res. Dev. | AwardedStock Option (right to buy) | 160,000 | 160,000 | SEC |